Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
Open Access
- 1 September 2018
- journal article
- editorial
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 13, 2999-3002
Abstract
Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort Timm Greulich,1 Sina Mager,1 Tanja Lucke,2 Andreas Rembert Koczulla,1 Robert Bals,3 Sebastian Fähndrich,3 Rudolf A Jörres,2 Peter Alter,1 Anne Kirsten,4 Claus Franz Vogelmeier,1 Henrik Watz4 1Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Centre Giessen and Marburg, Philipps-University, Member of the German Centre for Lung Research (DZL), Marburg, Germany; 2Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine Ludwig-Maximilians-Universität München, Munich, Germany; 3Department of Internal Medicine V, Pulmonology, Allergology, Respiratory and Intensive Care Medicine, Saarland Hospital, Homburg/Saar, Germany; 4Pulmonary Research Institute at Lungen Clinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Centre for Lung Research (DZL), Grosshansdorf, GermanyIt has been increasingly recognized that the numbers of blood eosinophils (eos) might be an important biomarker in patients with COPD to identify patients at risk for exacerba¬tions and for treatment to inhaled corticosteroid (ICS) treatment or anti-interleukin-5 therapy. However, data about the stability of blood eos counts over time are rare. We used data from the multicenter COSYCONET study to analyze the variability of eos by strata over a period of 18 months.Keywords
This publication has 7 references indexed in Scilit:
- Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2017
- Eosinophils in COPD: just another biomarker?The Lancet Respiratory Medicine, 2017
- Stability of Blood Eosinophils in Patients with Chronic Obstructive Pulmonary Disease and in Control Subjects, and the Impact of Sex, Age, Smoking, and Baseline CountsAmerican Journal of Respiratory and Critical Care Medicine, 2017
- Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trialThe Lancet Respiratory Medicine, 2016
- The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baselineRespiratory Medicine, 2016
- Eosinophilic inflammation in COPD: prevalence and clinical characteristicsEuropean Respiratory Journal, 2014
- Susceptibility to Exacerbation in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2010